Development of T cell immunity to norovirus and rotavirus in children under five years of age (Q64084491)

0 references

Heikki Hyöty

0 references

Mikael Knip

0 references

Timo Vesikari

0 references

Vesna Blazevic

Creative Commons Attribution 4.0 International

0 references

language of work or name

English

0 references

publication date

1 March 2019

0 references

0 references

0 references

0 references

3199

0 references

start time

1 March 2019

1 reference

April 2022 Public Data File from Crossref

copyrighted

0 references

cites work

Norovirus and Rotavirus disease severity in children: Systematic Review and Meta-Analysis

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

Developments in understanding acquired immunity and innate susceptibility to norovirus and rotavirus gastroenteritis in children

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

Fulfilling the promise of rotavirus vaccines: how far have we come since licensure?

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

Prevalence of norovirus GII-4 antibodies in Finnish children.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

Safety and Immunogenicity of Different Formulations of Norovirus Vaccine Candidate in Healthy Adults: A Randomized, Controlled, Double-Blind Clinical Trial

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

Safety and immunogenicity of an oral tablet norovirus vaccine, a phase I randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

Norovirus VLPs and rotavirus VP6 protein as combined vaccine for childhood gastroenteritis.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

Trivalent combination vaccine induces broad heterologous immune responses to norovirus and rotavirus in mice

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

Intranasal P particle vaccine provided partial cross-variant protection against human GII.4 norovirus diarrhea in gnotobiotic pigs

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

X-ray crystallographic structure of the Norwalk virus capsid

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

Replication of human noroviruses in stem cell-derived human enteroids

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

Human Norovirus Neutralized by a Monoclonal Antibody Targeting the Histo-Blood Group Antigen Pocket

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

Genotype considerations for virus-like particle-based bivalent norovirus vaccine composition

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

Type-specific and cross-reactive antibodies and T cell responses in norovirus VLP immunized mice are targeted both to conserved and variable domains of capsid VP1 protein.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

Multiple consecutive norovirus infections in the first 2 years of life

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

Norovirus Illness Is a Global Problem: Emergence and Spread of Norovirus GII.4 Variants, 2001–2007

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

The emergence and evolution of the novel epidemic norovirus GII.4 variant Sydney 2012.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

Norovirus genotypes in endemic acute gastroenteritis of infants and children in Finland between 1994 and 2007

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

Comparison of human saliva and synthetic histo-blood group antigens usage as ligands in norovirus-like particle binding and blocking assays.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

Prospects and Challenges in the Development of a Norovirus Vaccine

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

Norovirus vaccines under development

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

Rotavirus immune responses and correlates of protection

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

Rotavirus vaccination and infection induce VP6-specific IgA responses

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

Protective effect of naturally acquired homotypic and heterotypic rotavirus antibodies.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

Identification of an immunodominant CD4+ T cell epitope in the VP6 protein of rotavirus following intranasal immunization of BALB/c mice

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

Characterization of homologous and heterologous rotavirus-specific T-cell responses in infant and adult mice.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

Human rotavirus specific T cells: quantification by ELISPOT and expression of homing receptors on CD4+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

Rotavirus-specific T-cell responses in young prospectively followed-up children

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

A TGF-β mediated regulatory mechanism modulates the T cell immune response to rotavirus in adults but not in children

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

Immunity and correlates of protection for rotavirus vaccines

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

Evidence of immunity induced by naturally acquired rotavirus and Norwalk virus infection on two remote Panamanian islands

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

High serum levels of norovirus genotype-specific blocking antibodies correlate with protection from infection in children.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

Serum antibody responses in children with rotavirus diarrhea can serve as proxy for protection

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

Induction of homologous and cross-reactive GII.4-specific blocking antibodies in children after GII.4 New Orleans norovirus infection

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

Development and maturation of norovirus antibodies in childhood

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

Rotavirus vaccines: recent developments and future considerations.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

Memory T-cell response to rotavirus detected with a gamma interferon enzyme-linked immunospot assay

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

Rotavirus-specific humoral and cellular immune response after primary, symptomatic infection

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

Frequencies of virus-specific CD4(+) and CD8(+) T lymphocytes secreting gamma interferon after acute natural rotavirus infection in children and adults

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

Cellular and humoral immunity following Snow Mountain virus challenge

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

Heterotypic humoral and cellular immune responses following Norwalk virus infection

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

Norovirus-Specific Memory T Cell Responses in Adult Human Donors

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

Rotavirus-Specific Helper T Cell Responses in Newborns, Infants, Children, and Adults

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

Genetic analyses of norovirus GII.4 variants in Finnish children from 1998 to 2013.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

A time-resolved immunoassay to measure serum antibodies to the rotavirus VP6 capsid protein

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

Serum antibody responses to individual viral polypeptides in human rotavirus infections

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

T cell memory in the context of persistent herpes viral infections

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

Evolution of the immune system in humans from infancy to old age

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

A comparison of methods for purification and concentration of norovirus GII-4 capsid virus-like particles.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

Comparative immunogenicity in mice of rotavirus VP6 tubular structures and virus-like particles

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

Intradermal and intranasal immunizations with oligomeric middle layer rotavirus VP6 induce Th1, Th2 and Th17 T cell subsets and CD4+ T lymphocytes with cytotoxic potential

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39840-9

7 January 2021

Histo-blood group antigens as receptors for rotavirus, new understanding on rotavirus epidemiology and vaccine strategy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/30824789

12 December 2020